
Naples, Florida, November 20th, 2026, FinanceWire Artificial intelligence is moving deeper into medicine, and cancer care is emerging as an important area of application. Machine learning models are being used
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| GRAL | GRAIL Inc | 99.72 | 18.25 | 22.41% |
| Name | Price | % Change | |
|---|---|---|---|
| $99.72 | +22.41% |

Naples, Florida, November 20th, 2026, FinanceWire Artificial intelligence is moving deeper into medicine, and cancer care is emerging as an important area of application. Machine learning models are being used

Grail Inc (($GRAL)) has held its Q3 earnings call. Read on for the main highlights of the call. GRAIL’s earnings call struck a mostly positive tone, led by Galleri’s favorable

Piper Sandler raised the firm’s price target on Grail (GRAL) to $130 from $74 and keeps a Neutral rating on the shares. The firm is updating its estimates and price

Mizuho raised the firm’s price target on Grail (GRAL) to $110 from $100 and keeps a Neutral rating on the shares. Published first on TheFly – the ultimate source for

Canaccord Genuity analyst Kyle Mikson CFA maintained a Buy rating on GRAIL Inc today and set a price target of $150.00. Kyle Mikson CFA’s rating is based on several factors,

RBC Capital raised the firm’s price target on Grail (GRAL) to $100 from $84 and keeps a Sector Perform rating on the shares. The company’s Q3 results support the firm’s

Baird lowered the firm’s price target on Grail (GRAL) to $150 from $155 and keeps an Outperform rating on the shares. The firm updated its model following Q3 results. Published

Reports Q3 revenue $37.5M, consensus $44.21M. “GRAIL (GRAL) achieved significant milestones this quarter including a favorable vote for approval of Galleri at the FDA Advisory Committee,” said Josh Ofman, CEO.

TD Cowen raised the firm’s price target on Grail (GRAL) to $180 from $88 and keeps a Buy rating on the shares. The firm adjusted targets in the diagnostics space

Morgan Stanley raised the firm’s price target on Grail (GRAL) to $120 from $60 and keeps an Equal Weight rating on the shares. Published first on TheFly – the ultimate
| Name | Analyst | Analyst Firm | Rating | Analyst Price Target | Action | Date |
|---|---|---|---|---|---|---|
| hold | Reiterated | Nov 10, 2026 | ||||
| buy | Reiterated | Nov 9, 2026 | ||||
| hold | Reiterated | Nov 6, 2026 | ||||
| buy | Reiterated | Nov 5, 2026 | ||||
| buy | Reiterated | Nov 5, 2026 | ||||
| hold | Reiterated | Nov 5, 2026 | ||||
| buy | Reiterated | Nov 5, 2026 | ||||
| hold | Assigned | Nov 4, 2026 | ||||
| hold | Reiterated | Oct 13, 2026 | ||||
| buy | Reiterated | Oct 2, 2026 |
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| Feb 25, 2027TBA | $4.71B | $-2.38 | $45.58M | 0.09 | -11.04 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.